Comparative trough effects of formoterol and salmeterol on lymphocyte β2-adrenoceptor - Regulation and bronchodilatation

European Journal of Clinical Pharmacology

Volumn 55, Issue 6, 1999, Pages 431-436

  Aziz, I ^a   McFarlane, L C ^a   Lipworth, B J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Bronchodilatation; Downregulation; Polymorphism 2 adrenoceptor

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; FORMOTEROL; FORMOTEROL FUMARATE; GLYCINE; IPRATROPIUM BROMIDE; PLACEBO; SALMETEROL; SALMETEROL XINAFOATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ACTIVITY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SINGLE BLIND PROCEDURE; SPIROMETRY; TREATMENT OUTCOME; VITAL CAPACITY;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ALBUTEROL; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; ETHANOLAMINES; FEMALE; HUMANS; LYMPHOCYTES; MALE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; SINGLE-BLIND METHOD;

EID: 0032772835     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050652     Document Type: Article

References (19)

1. 2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in stable asthmatics. J Allergy Clin Immunol 101: 337-341
2. 2-adrenoceptor polymorphism is associated with susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 350: 995-999
3. Greening AP, Ind PW, Northfield M, Shaw G (1994) Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 344: 219-224
4. Woolcock A, Lundback B, Ringdal N, Jacques LA (1996) Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 153: 1481-1488
5. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, et al. (1997) Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 337: 1405-1411
6. National Institutes of Health (1997) National Asthma Education and Prevention Programme. Expert panel report II: guidelines for the diagnosis and management of asthma. National Institutes of Health, publication no 97-4051. Bethesda, MD
7. British Thoracic Society (1997) Guidelines on the management of asthma. Thorax 52[Suppl 1]: S1-S21
8. American Thoracic Society (1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136: 225-244
9. Dewar J, Wheatley A, Venn A, Morrison J, Britton J, Hall I (1998) β2-Adrenoceptor polymorphisms are in linkage disequilibrium but are not associated with asthma in adult population. Clin Exp Allergy 28: 442-448
10. American Thoracic Society (1987) Standardisation of spirometry-update. Am Rev Respir Dis 136: 1285-1298
11. Newnham DM, Coutie WJR, McFarlane LC, Lipworth BJ (1993) Comparison of parameters of in-vitro lymphocyte β2-adrenoceptor function in normal and asthmatic subjects. Eur J Clin Pharmacol 45: 535-538
12. 2-adrenoceptor polymorphism with lower airways reactivity in asthmatic subjects. Lancet 345: 1213-1214
13. 2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. J Allergy Clin Immunol 100: 261-265
14. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 100: 3184-3188
15. 2-agonist therapy in asthma. Eur Respir J 11: 589-593
16. Grove A, Lipworth BJ (1995) Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet 346: 201-206
17. Davis C, Connolly ME, Greenacre JK (1980) β-adrenoceptors in human lung, bronchus and lymphocyte. Br J Clin Pharmacol 10: 425-432
18. Hauck RW, Bohm M, Gengenbach S, Sunder-Plassmann L, Fruhmann G, Erdmann E (1990) Beta-2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline treated patients. Chest 98: 367-381
19. Hayes MJ, Quing F, Rhodes CG, Rahman SU, Ind PW, Sriskandon S, et al. (1996) In-vivo quantification of human pulmonary β-adrenoceptors effect of β-agonist therapy. Am J Respir Crit Care Med 154: 1277-1283